Orchestra BioMed Holdings (OBIO) Change in Receivables (2022 - 2026)
Orchestra BioMed Holdings (OBIO) posted quarterly Change in Receivables of -$11000.0 for Q1 2026, down 266.67% year-over-year from $6600.0 in Q1 2025, and down 125.58% quarter-over-quarter from $43000.0 in Q4 2025.
Orchestra BioMed Holdings (OBIO) Change in Receivables (2022 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has reported Change in Receivables for 5 consecutive years, with -$11000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Receivables fell 266.67% year-over-year to -$11000.0; the TTM figure through Mar 2026 stood at -$5000.0 (down 171.43% YoY), while the FY2025 annual figure was $3000.0, up 113.64% from the prior year.
- Change in Receivables fell to -$11000.0 in Q1 2026 per OBIO's latest filing, from $43000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $95000.0 in Q2 2023 and bottomed at -$85000.0 in Q3 2023.
- Historically, Change in Receivables has averaged -$3250.0 across 5 years, with a median of -$4500.0 in 2025.
- On a YoY basis, Change in Receivables climbed as much as 9400.0% in 2023 and fell as far as 631.25% in 2023.
- Orchestra BioMed Holdings' Change in Receivables stood at $16000.0 in 2022, then fell by 18.75% to $13000.0 in 2023, then slumped by 392.31% to -$38000.0 in 2024, then soared by 213.16% to $43000.0 in 2025, then tumbled by 125.58% to -$11000.0 in 2026.
- Business Quant data shows OBIO's Change in Receivables at -$11000.0 in Q1 2026, $43000.0 in Q4 2025, and -$31000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Orchestra BioMed Holdings | 265.06 Mn | 80.63 Mn | 63,000.00 | -33,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -33,000.00 |
| Jun 30, 2026 | -33,000.00 |
| Mar 31, 2026 | -11,000.00 |
| Mar 31, 2026 | -11,000.00 |
| Dec 31, 2025 | 43,000.00 |
| Dec 31, 2025 | 43,000.00 |
| Sep 30, 2025 | -31,000.00 |
| Sep 30, 2025 | -31,000.00 |
| Jun 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -6,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Dec 31, 2024 | -38,000.00 |
| Dec 31, 2024 | -38,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Mar 31, 2024 | -32,000.00 |
| Mar 31, 2024 | -32,000.00 |